EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Baseline colitogenicity and acute perturbations of gut microbiota in immunotherapy-related colitis

Joan Shang iD, Diane Marie Del Valle iD, Graham J Britton iD, K R Mead iD, Urvija Rajpal iD, Alice Chen-Liaw iD, Ilaria Mogno iD, Zhihua Li iD, Rajita Menon iD, Edgar Gonzalez-Kozlova iD, Arielle Elkrief iD, Jonathan U Peled iD und 7 weitere

Journal of Experimental Medicine · 06.01.2025 · 222 (1)

DOI: 10.1084/jem.20232079 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Experimental Medicine, online erschienen am 12.12.2024. Verfasst von Joan Shang und 18 weiteren Autor:innen. Beteiligte Einrichtung: Precision Immunology Institute, Icahn School of Medicine at Mount Sinai , New York, NY, USA. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Colitis, Immunotherapy. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIDDK NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunotherapy-related colitis (irC) frequently emerges as an immune-related adverse event during immune checkpoint inhibitor therapy and is presumably influenced by the gut microbiota. We longitudinally studied microbiomes from 38 ICI-treated cancer patients. We compared 13 ICI-treated subjects who developed irC against 25 ICI-treated subjects who remained irC-free, along with a validation cohort. Leveraging a preclinical mouse model, predisease stools from irC subjects induced greater colitigenicity upon transfer to mice. The microbiota during the first 10 days of irC closely resembled inflammatory bowel disease microbiomes, with reduced diversity, increased Proteobacteria and Veillonella, and decreased Faecalibacterium, which normalized before irC remission. These findings highlight the irC gut microbiota as functionally distinct but phylogenetically similar to non-irC and healthy microbiomes, with the exception of an acute, transient disruption early in irC. We underscore the significance of longitudinal microbiome profiling in developing clinical avenues to detect, monitor, and mitigate irC in ICI therapy cancer patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeColitisImmunotherapyAnimalsHumansMiceFemaleMaleImmune Checkpoint InhibitorsMice, Inbred C57BLMiddle AgedAgedFecesNeoplasms

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Precision Immunology Institute, Icahn School of Medicine at Mount Sinai , New York, NY, USA.
  • Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai , New York, NY, USA.
  • Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai , New York, NY, USA.
  • Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai , New York, NY, USA.
  • Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Vedanta Biosciences , Cambridge, MA, USA.

ORCID-Profile: Joan Shang, Diane Marie Del Valle, Graham J Britton, K R Mead, Urvija Rajpal, Alice Chen-Liaw, Ilaria Mogno, Zhihua Li, Rajita Menon, Edgar Gonzalez-Kozlova, Arielle Elkrief, Jonathan U Peled, Tina Ruth Gonsalves, Neil J Shah, Michael Postow, Jean-Frederic Colombel, Sacha Gnjatic, David M Faleck, Jeremiah J Faith

Förderung

  • NCI NIH HHS
  • NIDDK NIH HHS
  • NHLBI NIH HHS
  • NIH HHS
  • Memorial Sloan-Kettering Cancer Center
  • National Heart, Lung, and Blood Institute
  • National Institutes of Health
  • National Cancer Institute

Zitieren

APA

Shang, J., Del Valle, D. M., Britton, G. J., Mead, K. R., Rajpal, U., Chen-Liaw, A., Mogno, I., Li, Z., Menon, R., Gonzalez-Kozlova, E., Elkrief, A., Peled, J. U., Gonsalves, T. R., Shah, N. J., Postow, M., Colombel, J. F., Gnjatic, S., Faleck, D. M., & Faith, J. J. (2025). Baseline colitogenicity and acute perturbations of gut microbiota in immunotherapy-related colitis. Journal of Experimental Medicine, 222(1). https://doi.org/10.1084/jem.20232079

Vancouver

Shang J, Del Valle DM, Britton GJ, Mead KR, Rajpal U, Chen-Liaw A, et al. Baseline colitogenicity and acute perturbations of gut microbiota in immunotherapy-related colitis. Journal of Experimental Medicine. 2025;222(1). doi:10.1084/jem.20232079

BibTeX
@article{Shang2025,
  author = {Shang, Joan and Del Valle, Diane Marie and Britton, Graham J and Mead, K R and Rajpal, Urvija and Chen-Liaw, Alice and Mogno, Ilaria and Li, Zhihua and Menon, Rajita and Gonzalez-Kozlova, Edgar and Elkrief, Arielle and Peled, Jonathan U and Gonsalves, Tina Ruth and Shah, Neil J and Postow, Michael and Colombel, Jean-Frederic and Gnjatic, Sacha and Faleck, David M and Faith, Jeremiah J},
  title = {Baseline colitogenicity and acute perturbations of gut microbiota in immunotherapy-related colitis},
  journal = {Journal of Experimental Medicine},
  year = {2025},
  volume = {222},
  number = {1},
  doi = {10.1084/jem.20232079}
}
Kostenlos starten →